netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services

Welcome to the Milton Keynes Formulary
For use by all primary and secondary care prescribers within Milton Keynes

Useful Links

MKUH Tools Drug Safety Update  CAS Central Alerting System 
UpToDate Antimicrobial Microguide webview (Secondary Care) Antimicrobial Guidelines     (Secondary Care)
Clinical Guides from NHSE during Covid-19 Monitoring Guidance for Specific Drugs during Covid-19 General Prescribing Information & Policies
Antimicrobial Guidelines: Primary Care (short form) Antimicrobial Guidelines: Primary Care (full guide) NICE Guidance

Shared Care Guidelines (SCG)

Patient Information Leaflets (PIL) Prescribing Newsletters
MKPAG Meeting Dates & Minutes MKPAG Terms of Reference (TOR)

MKPAG Application Forms (formulary, SCG, NFD)

CCG Prescribing Group Meeting Minutes & TOR CCG Prescribing Group Archived Minutes M&TC Meeting Archived Minutes



News Feed

COVID-19: NICE rapid guideline (NG191) on managing Covid-19 now published (March 2021), last updated June 2021

Supply Disruption Alert - Docusate sodium 100mg capsules  (Jan 2021) - expected to last until end of April 2021

Previous Supply Disruption Alert NOW RESOLVED - Sodium bicarbonate Polyfusors of all strengths  (June 2020)

Supply Disruption Alert - Danazol 100mg and 200mg capsules (June 2020)

Supply Disruption Alert - Ativan (Lorazepam) injection 4mg in 1ml (updated May 2020)

Supply Disruption Alert -

Ranitidine: All formulations (updated June 2020)

Ranitidine: All formulations (updated May 2020)

>>> more news


For further medicines and prescribing related guidance and documents from the joint Bedfordshire, Luton and Milton Keynes Clinical Commissioning Group (BLMK CCG), please visit Home - BLMK CCG.

Please note that the Milton Keynes Formulary is separate to the Bedfordshire & Luton Formulary and applies to the Milton Keynes part of BLMK only.


If you would like to provide any feedback on the formulary or if you have any questions or queries, please complete the feedback form under the "Feedback" tab on the top of the home page. Alternatively, please send an email to


Traffic Light Status Information

Status Description


Routine prescribing within licensed indication  

Amber 1

Specialist recommendation followed by GP initiation and continuation  

Amber 2

Specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation   

Amber 3

Specialist initiation and stabilisation followed by GP continuation  

Amber SCG

Specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline  


Hospital or specialist prescribing only  

Red Red

These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.  


   Visits = 39404
   Last updated: 28/07/2021 18:20:30